Vland Biotech(603739)
Search documents
青岛蔚蓝生物股份有限公司2025年第三季度报告
Shang Hai Zheng Quan Bao· 2025-10-28 21:46
Core Points - The company has announced the cancellation of its supervisory board and the revision of its articles of association, with the responsibilities of the supervisory board being transferred to the audit committee of the board of directors [30][31]. - The company held its 21st meeting of the fifth board of directors on October 28, 2025, where several important resolutions were passed, including the approval of the third quarter report for 2025 [9][10]. - The company plans to hold its first extraordinary general meeting of 2025 on November 13, 2025, to discuss the cancellation of the supervisory board and other governance matters [27]. Financial Data - The third quarter financial report for 2025 has been prepared but is not audited [3][4]. - The report includes significant non-recurring gains and losses, although specific amounts are not detailed in the provided documents [4]. Governance Changes - The company will no longer have a supervisory board, and its functions will be assumed by the audit committee, with necessary amendments made to the articles of association [31]. - Various governance documents and rules are being revised or established to enhance the company's operational standards, including rules for shareholder meetings and board meetings [16][20][21]. Shareholder Information - The company has confirmed that the resolutions passed during the board meeting received unanimous support, with all five directors voting in favor [12][15][28].
蔚蓝生物(603739.SH):第三季度净利润3506.29万元,同比增长205.02%
Ge Long Hui A P P· 2025-10-28 18:17
Core Viewpoint - The company reported a year-on-year increase in revenue and net profit for the third quarter, indicating positive financial performance despite a decline in net profit excluding non-recurring gains [1] Financial Performance - The company achieved operating revenue of 364 million yuan in the third quarter, representing a year-on-year growth of 8.09% [1] - The net profit attributable to shareholders reached 35.06 million yuan, showing a significant year-on-year increase of 205.02% [1] - The net profit attributable to shareholders after deducting non-recurring gains was 6.93 million yuan, reflecting a year-on-year decline of 12.43% [1] - The basic earnings per share were reported at 0.14 yuan [1]
10月28日这些公告有看头
Di Yi Cai Jing· 2025-10-28 14:10
Major Events - *ST Zhengping's stock will be suspended for investigation starting October 29, 2025, due to a significant price increase of 152.42% from September 1 to October 28, 2025, with 21 days of trading halts and 5 instances of abnormal trading fluctuations [2] - Gongjin Co. announced that its major shareholder is planning a share transfer that may lead to a change in control, resulting in the stock being suspended from October 27, 2025, for up to 3 trading days [2] - Jiuquan Technology's wholly-owned subsidiary plans to invest 150 million yuan in establishing an industrial fund focused on chips and integrated circuits [2] Company Announcements - YN Holdings decided to terminate investment in 17 distributed photovoltaic projects originally planned for a total investment of 1.197 billion yuan due to changes in market conditions [3] - Awan New Materials announced a one-day stock suspension on October 29, 2025, due to a tender offer from Shanghai Zhiyuan Hengyue Technology Partnership, aiming to acquire 149,243,840 shares at 7.78 yuan per share [4] - Dahua Intelligent clarified that it currently has no business related to quantum technology despite market speculation [5] Financial Performance - Ganfeng Lithium reported a net profit of 557 million yuan for Q3 2025, a year-on-year increase of 364.02%, with revenues of 6.249 billion yuan, up 44.10% [6] - Light Media's net profit for Q3 2025 reached 1.06 billion yuan, a 993.71% increase, with revenues of 374 million yuan, up 247.54% [6] - Hainan Airport reported a net profit of 64.35 million yuan for the first three quarters of 2025, a decline of 69.77% [7] - Su Li Co. achieved a net profit of 59.42 million yuan in Q3 2025, a 2750% increase, with revenues of 762 million yuan, up 26% [7] - Yutong Bus reported a net profit of 1.357 billion yuan for Q3 2025, a 78.98% increase, with revenues of 10.237 billion yuan, up 32.27% [9] Share Buybacks - Haida Group plans to repurchase shares worth between 1 billion to 1.6 billion yuan for capital reduction and employee stock ownership plans, with a maximum price of 62 yuan per share [20] - Liyuan Information intends to repurchase shares totaling 20 million to 30 million yuan, with a maximum price of 15 yuan per share [21] Major Contracts - Baiao Intelligent won a project worth 97.22 million yuan from a large state-owned company [22] - Guangdong Construction signed a construction contract worth 1.924 billion yuan for a project in Guangzhou, which will enhance its business scale and profitability [22] - Guangqi Technology's subsidiary signed contracts for mass production of metamaterials worth a total of 215 million yuan [23]
蔚蓝生物:2025年第三季度归属于上市公司股东的净利润同比增长205.02%
Zheng Quan Ri Bao Zhi Sheng· 2025-10-28 12:13
Core Insights - The company reported a revenue of 363,599,708.49 yuan for the third quarter of 2025, representing a year-on-year growth of 8.09% [1] - The net profit attributable to shareholders of the listed company was 35,062,856.99 yuan, showing a significant year-on-year increase of 205.02% [1]
晚间公告丨10月28日这些公告有看头
Di Yi Cai Jing· 2025-10-28 10:33
Core Viewpoint - The news summarizes important announcements from various companies, highlighting stock suspensions, significant profit growth, and major contracts signed, which may present investment opportunities and insights into market trends [1][2]. Stock Suspensions - *ST Zhengping announced that its stock will be suspended from trading starting October 29, 2025, due to a significant price increase of 152.42% from September 1 to October 28, 2025, and abnormal trading fluctuations [3]. - Gongjin Co. announced a stock suspension starting October 27, 2025, due to the major shareholder planning a share transfer that may lead to a change in control [4]. Investment Activities - Juyuan Technology's subsidiary plans to invest 150 million yuan in establishing an industrial fund focused on chips, integrated circuits, and other high-growth sectors [5]. - YN Holdings decided to terminate investments in 17 distributed photovoltaic projects, originally planned to cost 1.197 billion yuan, due to changes in market conditions [6]. Earnings Reports - Suliy Co. reported a 2750% increase in net profit for Q3 2025, with revenue of 762 million yuan, up 26% year-on-year [8]. - Xianda Co. reported a net profit of 59.85 million yuan for Q3 2025, a 5447% increase, despite a 5.59% decline in revenue [9]. - Yutong Bus reported a net profit of 1.357 billion yuan for Q3 2025, a 78.98% increase, with revenue of 10.237 billion yuan, up 32.27% [10]. - Juxin Technology reported a net profit of 60.27 million yuan for Q3 2025, a 101.09% increase, with revenue of 273 million yuan, up 46.64% [11]. - Guanghong Technology reported a net profit of 99.61 million yuan for Q3 2025, a 99.68% increase, with revenue of 2.937 billion yuan, up 57.46% [12]. - Mingzhi Electric reported a net profit of 22.88 million yuan for Q3 2025, a 215.97% increase, with revenue of 729 million yuan, up 28.98% [13]. - Zhongwei Semiconductor reported a net profit of 65.82 million yuan for Q3 2025, a 3.66% decrease, with revenue of 269 million yuan, up 21.88% [14]. - Yiming Pharmaceutical reported a net profit of 44.21 million yuan for Q3 2025, a 1934.12% increase, with revenue of 178 million yuan, up 10.37% [15]. - Weilan Bio reported a net profit of 35.06 million yuan for Q3 2025, a 205.02% increase, with revenue of 364 million yuan, up 8.09% [16]. - Baiyunshan reported a net profit of 794 million yuan for Q3 2025, a 30.28% increase, with revenue of 19.771 billion yuan, up 9.74% [17]. - Giant Network reported a net profit of 640 million yuan for Q3 2025, an 81.19% increase, with revenue of 1.706 billion yuan, up 115.63% [18]. Share Buybacks - Haida Group announced a plan to repurchase shares worth between 1 billion and 1.6 billion yuan, aimed at reducing registered capital and implementing employee stock ownership plans [20]. Major Contracts - Bai'ao Intelligent announced it won a project worth 97.22 million yuan from a large state-owned company [22]. - Guangdong Construction signed a construction contract worth 1.924 billion yuan for a project in Guangzhou, with a duration of 1365 days [23][24].
蔚蓝生物(603739.SH)发布前三季度业绩,归母净利润6178万元,同比增长51.24%
智通财经网· 2025-10-28 08:26
Core Insights - The company reported a revenue of 1.016 billion yuan for the first three quarters of 2025, representing a year-on-year growth of 7.42% [1] - The net profit attributable to shareholders reached 61.78 million yuan, showing a significant year-on-year increase of 51.24% [1] - The non-recurring net profit was 22.93 million yuan, which reflects a slight decline of 1.47% year-on-year [1] - The basic earnings per share stood at 0.24 yuan [1]
蔚蓝生物(603739) - 青岛蔚蓝生物股份有限公司关于召开2025年第三季度业绩说明会的公告
2025-10-28 08:25
证券代码:603739 证券简称:蔚蓝生物 公告编号:2025-049 青岛蔚蓝生物股份有限公司 关于召开 2025 年第三季度业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: 会议召开时间:2025 年 11 月 5 日(星期三)上午 9:00-10:00 会 议 召 开 地 点 : 上 海 证 券 交 易 所 上 证 路 演 中 心 ( 网 址 : http://roadshow.sseinfo.com/) 会议召开方式:上证路演中心网络互动 投资者可于 2025 年 10 月 29 日(星期三)至 11 月 4 日(星期二)16:00 前登录上证路演中心网站首页点击"提问预征集"栏目或通过公司邮箱 vland@vlandgroup.com 进行提问。公司将在说明会上对投资者普遍关注的问题 进行回答。 青岛蔚蓝生物股份有限公司(以下简称"公司")已于 2025 年 10 月 29 日发 布公司 2025 年第三季度报告,为便于广大投资者更全面深入地了解公司 2025 年第三季度的经营成果、财务状 ...
蔚蓝生物(603739) - 青岛蔚蓝生物股份有限公司关于增值税税率调整的公告
2025-10-28 08:25
青岛蔚蓝生物股份有限公司 关于增值税税率调整的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 一、增值税税率调整的基本情况 根据《财政部 国家税务总局关于部分货物适用增值税低税率和简易办法征 收增值税政策的通知》(【财税 2009】9 号)规定,一般纳税人销售自产的用微 生物、微生物代谢产物、动物毒素、人或动物的血液或组织制成的生物制品,可 选择按照简易办法依照 3%征收率计算缴纳增值税。 证券代码:603739 证券简称:蔚蓝生物 公告编号:2025-050 特此公告。 青岛蔚蓝生物股份有限公司董事会 2025 年 10 月 29 日 根据主管税务机关的通知和要求,公司部分产品由简易办法计算缴纳增值税 调整为一般计税办法计算缴纳增值税,增值税税率将由 3%调整至 13%。 二、对公司的影响 本次增值税税率调整不会影响公司 2024 年及以前年度业绩。预计自 2025 年起,公司部分产品适用税率将上调,对公司利润总额产生一定的间接影响。 为积极应对,公司已采取措施,包括优化产品定价与结构、强化税收管理与 成本控制、紧贴市 ...
蔚蓝生物(603739) - 青岛蔚蓝生物股份有限公司2025年度第三季度主要经营数据公告
2025-10-28 08:25
证券代码:603739 证券简称:蔚蓝生物 公告编号:2025-048 青岛蔚蓝生物股份有限公司 2025 年度第三季度主要经营数据公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 青岛蔚蓝生物股份有限公司(以下简称"公司")根据上海证券交易所《上 市公司行业信息披露指引第十四号——食品制造》的要求,现将公司 2025 年第 三季度主要经营数据披露如下: | 地区 | | 2025 年第三季度 | | | | --- | --- | --- | --- | --- | | | 期初 | 增加 | 减少 | 期末 | | 东北 | 38 | 12 | 8 | 42 | | 华北 | 76 | 33 | 20 | 89 | | 华东 | 331 | 93 | 58 | 366 | | 华南 | 55 | 15 | 9 | 61 | | 华中 | 79 | 14 | 30 | 63 | | 西北 | 17 | 5 | 6 | 16 | | 西南 | 40 | 13 | 11 | 42 | | 总计 | 636 | 185 | 1 ...
蔚蓝生物(603739) - 青岛蔚蓝生物股份有限公司关于取消监事会、修订公司章程及修订、制定公司部分治理制度的公告
2025-10-28 08:25
证券代码:603739 证券简称:蔚蓝生物 公告编号:2025-047 青岛蔚蓝生物股份有限公司 关于取消监事会、修订《公司章程》及修订、制定 公司部分治理制度的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 青岛蔚蓝生物股份有限公司(以下简称"公司")于 2025 年 10 月 28 日召开 了第五届董事会第二十一次会议,审议通过了《关于取消监事会并修订<公司章 程>的议案》和《关于修订、制定公司部分治理制度的议案》,现将具体内容公告 如下: 一、取消监事会的情况 根据《中华人民共和国公司法》《关于新<公司法>配套制度规则实施相关过 渡期安排》以及证监会《上市公司章程指引(2025 年修订)》等相关规定,公司 将不再设置监事会,其职权由董事会审计委员会行使,并对《公司章程》部分条 款进行修订。 在公司股东会审议通过取消监事会事项前,公司监事会及监事仍将严格按照 法律法规及《公司章程》等规范性文件的要求继续履行职能,维护公司及全体股 东的合法利益。自公司股东会审议通过后,公司监事会将予以取消,现任各位监 事的职务自然免除 ...